General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial
This is a large pragmatic multicenter trial comparing maintenance of general anesthesia with total intravenous anesthesia using propofol versus volatile agent (sevoflurane, isoflurane, or desflurane) during cancer surgery. The primary endpoint is all-cause mortality.
Anesthesia, General|Surgical Oncology
DRUG: Propofol|DRUG: Volatile Agent
All-cause mortality, Time to event, 2 year minimum
Recurrence free survival, Time to event, Minimum 2 years|All-cause mortality as a binary outcome, 2 years
This is a large pragmatic multicenter trial comparing maintenance of general anesthesia with total intravenous anesthesia using propofol versus volatile agent (sevoflurane, isoflurane, or desflurane) during cancer surgery. The primary endpoint is all-cause mortality.